Nontuberculous mycobacteria pulmonary disease: A retrospective analysis.
10.11817/j.issn.1672-7347.2019.04.014
- Author:
Shenggang LIU
1
;
Xin GAO
1
;
Jinqi ZHU
1
;
Jianbo CHEN
1
;
Hongzhong YANG
1
;
Lujuan HE
1
Author Information
1. Respiratory Diagnosis and Treatment Center, Changsha Central Hospital, Changsha 410004, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Female;
Humans;
Male;
Middle Aged;
Mycobacterium Infections, Nontuberculous;
Nontuberculous Mycobacteria;
Retrospective Studies
- From:
Journal of Central South University(Medical Sciences)
2019;44(4):432-436
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the clinical characteristics and drug resistance in patients with non-tuberculous mycobacteria (NTM) pulmonary disease in Changsha Central Hospital of Hunan Province in recent three years.
Methods: The clinical data of 153 patients with NTM pulmonary disease, who were diagnosed in Changsha Central Hospital of Hunan Province from February 2014 to May 2017, were retrospectively analyzed. According to the concentration of drug sensitivity test, the patients were divided into a low concentration group and a high concentration group. The status of drug sensitivity and drug resistance were examined.
Results: Among 153 patients, 79 patients (51.63%) were male, 74 patients (48.37%) were female. The mean ages were (60.27±19.46) years. The NTM pulmonary disease mainly occurred in the individuals with bronchiectasis, and the course of disease was long (mean 7.8 years). The clinical symptoms were not specific and mostly misdiagnosed as pulmonary tuberculosis (92.81%). Mycobacterium avium-intracellulare (56.21%) and mycobacterium chelonae-abscess (20.92%) were the majority. The drug-resistance rate of the first-line and second-line anti-tuberculosis drugs was high. The majority was resistant to more than eight drugs, 38.56% patients in the low concentration group were resistant to total drugs, and 25.49% patients in the high concentration group were resistant to total drugs.
Conclusion: The NTM pulmonary disease is easily misdiagnosed, and the drug resistance rate is high. Identification of mycobacterium species and detection of drug sensitivity play an important role in clinical diagnosis and treatment.
